These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 19155234

  • 1. DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis.
    Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Kerstens PJ, Nielen MM, Vos K, van Schaardenburg D, Speyer I, Seys PE, Breedveld FC, Allaart CF, Dijkmans BA.
    Ann Rheum Dis; 2010 Jan; 69(1):65-9. PubMed ID: 19155234
    [Abstract] [Full Text] [Related]

  • 2. Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort.
    Soubrier M, Lukas C, Sibilia J, Fautrel B, Roux F, Gossec L, Patternotte S, Dougados M.
    Ann Rheum Dis; 2011 Apr; 70(4):611-5. PubMed ID: 21242235
    [Abstract] [Full Text] [Related]

  • 3. Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study.
    Allaart CF, Breedveld FC, Dijkmans BA.
    J Rheumatol Suppl; 2007 Nov; 80():25-33. PubMed ID: 17985420
    [Abstract] [Full Text] [Related]

  • 4. Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis.
    van der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Güler-Yüksel M, Zwinderman AH, Kerstens PJ, van der Lubbe PA, de Beus WM, Grillet BA, Ronday HK, Huizinga TW, Breedveld FC, Dijkmans BA, Allaart CF.
    Ann Rheum Dis; 2009 Jun; 68(6):914-21. PubMed ID: 18662933
    [Abstract] [Full Text] [Related]

  • 5. Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.
    Aletaha D, Smolen JS.
    Arthritis Rheum; 2011 Dec; 63(12):3702-11. PubMed ID: 21953215
    [Abstract] [Full Text] [Related]

  • 6. Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study.
    Allaart CF, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Breedveld FC, Dijkmans BA, FARR study group.
    Clin Exp Rheumatol; 2006 Dec; 24(6 Suppl 43):S-77-82. PubMed ID: 17083767
    [Abstract] [Full Text] [Related]

  • 7. Do radiographic joint damage and disease activity influence functional disability through different mechanisms? Direct and indirect effects of disease activity in established rheumatoid arthritis.
    Nair SC, Bijlsma JW, van der Werf JH, van der Veen MJ, Linn-Rasker SP, Vreugdenhil S, Lafeber FP, Welsing PM.
    J Rheumatol; 2013 Sep; 40(9):1505-12. PubMed ID: 23818710
    [Abstract] [Full Text] [Related]

  • 8. Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.
    van der Kooij SM, le Cessie S, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van Zeben D, Kerstens PJ, Hazes JM, van Schaardenburg D, Breedveld FC, Dijkmans BA, Allaart CF.
    Ann Rheum Dis; 2009 Jul; 68(7):1153-8. PubMed ID: 18930988
    [Abstract] [Full Text] [Related]

  • 9. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA).
    Hetland ML, Ejbjerg B, Hørslev-Petersen K, Jacobsen S, Vestergaard A, Jurik AG, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, Tarp U, Skjødt H, Pedersen JK, Majgaard O, Svendsen AJ, Ellingsen T, Lindegaard H, Christensen AF, Vallø J, Torfing T, Narvestad E, Thomsen HS, Ostergaard M, CIMESTRA study group.
    Ann Rheum Dis; 2009 Mar; 68(3):384-90. PubMed ID: 18388160
    [Abstract] [Full Text] [Related]

  • 10. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial.
    Dale J, Stirling A, Zhang R, Purves D, Foley J, Sambrook M, Conaghan PG, van der Heijde D, McConnachie A, McInnes IB, Porter D.
    Ann Rheum Dis; 2016 Jun; 75(6):1043-50. PubMed ID: 27026689
    [Abstract] [Full Text] [Related]

  • 11. Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort.
    Mueller RB, Kaegi T, Finckh A, Haile SR, Schulze-Koops H, von Kempis J, SCQM physicians.
    Rheumatology (Oxford); 2014 Apr; 53(4):671-7. PubMed ID: 24352338
    [Abstract] [Full Text] [Related]

  • 12. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.
    Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Ronday HK, Han KH, Westedt ML, Gerards AH, van Groenendael JH, Lems WF, van Krugten MV, Breedveld FC, Dijkmans BA.
    Arthritis Rheum; 2005 Nov; 52(11):3381-90. PubMed ID: 16258899
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial.
    Rezaei H, Saevarsdottir S, Forslind K, Albertsson K, Wallin H, Bratt J, Ernestam S, Geborek P, Pettersson IF, van Vollenhoven RF.
    Ann Rheum Dis; 2012 Feb; 71(2):186-91. PubMed ID: 21930734
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treating to target matrix metalloproteinase 3 normalisation together with disease activity score below 2.6 yields better effects than each alone in rheumatoid arthritis patients: T-4 Study.
    Urata Y, Uesato R, Tanaka D, Nakamura Y, Motomura S.
    Ann Rheum Dis; 2012 Apr; 71(4):534-40. PubMed ID: 22021897
    [Abstract] [Full Text] [Related]

  • 19. Rheumatoid arthritis patients with continued low disease activity have similar outcomes over 10 years, regardless of initial therapy.
    Bergstra SA, Landewé RBM, Huizinga TWJ, Allaart CF.
    Rheumatology (Oxford); 2017 Oct 01; 56(10):1721-1728. PubMed ID: 28957556
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.